Brief: Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter And Full Year 2021 Financial Results
Feb 8 (Reuters) - Deciphera Pharmaceuticals Inc DCPH.O :
* DECIPHERA PHARMACEUTICALS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS
* Q4 LOSS PER SHARE $1.51
* Q4 REVENUE $24.2 MILLION
* CASH, CASH EQUIVALENTS TO ENABLE COMPANY TO FUND ITS OPERATING AND CAPITAL
EXPENDITURES INTO 2024
* Q4 EARNINGS PER SHARE VIEW $-1.38, REVENUE VIEW $23.3 MILLION -- REFINITIV
IBES
DATA
Source text for Eikon: ID:nBw6xsj03a
Further company coverage: DCPH.O
Recent news on Deciphera Pharmaceuticals
See all newsBrief: Deciphera Pharmaceuticals Announces Oral Presentation Of Results From Phase 3 Study of Vimseltinib In Patients With Tenosynovial Giant Cell Tumor
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Deals of the day-Mergers and acquisitions